𝔖 Bobbio Scriptorium

✦ LIBER ✦

Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant

✍ Scribed by Tse, W T; Duerst, R; Schneiderman, J; Chaudhury, S; Jacobsohn, D; Kletzel, M

Book ID: 109840605
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 455 KB
Volume: 44
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2008.437

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of a Test Dose of Intra

Pharmacokinetics of a Test Dose of Intravenous Busulfan Guide Dose Modifications to Achieve an Optimal Area Under the Curve of a Single Daily Dose of Intravenous Busulfan in Children Undergoing a Reduced-Intensity Conditioning Regimen with Hematopoietic Stem Cell Transplantation

✍ Morris Kletzel; David Jacobsohn; Reggie Duerst 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 194 KB

A test dose of I.V. busulfan (BU) is pre

A test dose of I.V. busulfan (BU) is predictive of the area under the curve (AUC) of a single daily dose of I.V. bu in pediatric patients undergoing a reduced intensity (RI) hematopoietic stem cell transplant (HSCT)

✍ M. Kletzel; D. Jacobsohn; R. Duerst 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 70 KB

229: Twice-Daily Intravenous (IV) Busulf

229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults

✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB